Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 2, 2011, Pages 187-197

  Kuraitis, Drew ^a,b   Hou, Chenchen ^a,b   Zhang, Yan ^a,b   Vulesevic, Branka ^a   Sofrenovic, Tanja ^a,b   McKee, Daniel ^a,b   Sharif, Zahra ^a   Ruel, Marc ^a,b   Suuronen, Erik J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Angiogenesis; Cell culture; Cell therapy; Collagen; Hydrogel

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CELL ADHESION; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CIRCULATING ANGIOGENIC CELL; CONTROLLED STUDY; CULTURE TECHNIQUE; ENDOTHELIUM CELL; ENGRAFTMENT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEG REVASCULARIZATION; LIMB ISCHEMIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STARVATION; STEM CELL; UPREGULATION;

ANIMALS; ARTERIOLES; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HINDLIMB; HUMANS; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; REPERFUSION;

EID: 79959526392     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.04.011     Document Type: Article

References (44)

1. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105:1527-1536.
2. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000, 97:3422-3427.
3. Schatteman G.C., Hanlon H.D., Jiao C., Dodds S.G., Christy B.A. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000, 106:571-578.
4. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
5. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
6. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
7. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
8. Cho H.J., Lee N., Lee J.Y., Choi Y.J., Ii M., Wecker A., et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007, 204:3257-3269.
9. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
10. Metallo C.M., Mohr J.C., Detzel C.J., de Pablo J.J., Van Wie B.J., Palecek S.P. Engineering the stem cell microenvironment. Biotechnol Prog 2007, 23:18-23.
11. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
12. Zhang Y., Thorn S., DaSilva J., Lamoreux M., deKemp R., Beanlands R., et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells. Circ Cardiovasc Imaging 2008, 1:197-204.
13. Suuronen E.J., Veinot J.P., Wong S., Kapila V., Price J., Griffith M., et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006, 114:I138-I144.
14. Suuronen E.J., Nakamura M., Watsky M.A., Stys P.K., Muller L.J., Munger R., et al. Innervated human corneal equivalents as in vitro models for nerve-target cell interactions. FASEB J 2004, 18:170-172.
15. Gagnon E., Cattaruzzi P., Griffith M., Muzakare L., LeFlao K., Faure R., et al. Human vascular endothelial cells with extended life spans: in vitro cell response, protein expression, and angiogenesis. Angiogenesis 2002, 5:21-33.
16. Limbourg A., Korff T., Napp L.C., Schaper W., Drexler H., Limbourg F.P. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 2009, 4:1737-1746.
17. Hristov M., Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004, 8:498-508.
18. Srivastava S.P., Kumar K.U., Kaufman R.J. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem 1998, 273:2416-2423.
19. Dai T., Zheng H., Fu G. Hypoxia confers protection against apoptosis via the PI3K/Akt pathway in endothelial progenitor cells. Acta Pharmacol Sin 2008, 29:1425-1431.
20. Hur J., Yoon C.H., Lee C.S., Kim T.Y., Oh I.Y., Park K.W., et al. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 2007, 25:1769-1778.
21. Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999, 274:16349-16354.
22. Morales-Ruiz M., Fulton D., Sowa G., Languino L.R., Fujio Y., Walsh K., et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 2000, 86:892-896.
23. Radisavljevic Z., Avraham H., Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000, 275:20770-20774.
24. Lu S., Lu C., Han Q., Li J., Du Z., Liao L., et al. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology 2011, 279:189-195.
25. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
26. Mogi M., Walsh K., Iwai M., Horiuchi M. Akt-FOXO3a signaling affects human endothelial progenitor cell differentiation. Hypertens Res 2008, 31:153-159.
27. Fukushima S., Varela-Carver A., Coppen S.R., Yamahara K., Felkin L.E., Lee J., et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007, 115:2254-2261.
28. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9:180-186.
29. Sharma G.D., He J., Bazan H.E. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 2003, 278:21989-21997.
30. Deng M., Chen W.L., Takatori A., Peng Z., Zhang L., Mongan M., et al. A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing. Mol Biol Cell 2006, 17:3446-3455.
31. Uraoka M., Ikeda K., Nakagawa Y., Koide M., Akakabe Y., Nakano-Kurimoto R., et al. Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system. Biochem Biophys Res Commun 2009, 390:1202-1207.
32. Srinivasan R., Zabuawala T., Huang H., Zhang J., Gulati P., Fernandez S., et al. Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One 2009, 4:e8283.
33. Alavi A., Hood J.D., Frausto R., Stupack D.G., Cheresh D.A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 2003, 301:94-96.
34. Tsai K., Kao S., Wang C., Wang Y., Wang J., Hung S. Type I collagen promotes proliferation and osteogenesis of human mesenchymal stem cells via activation of ERK and Akt pathways. J Biomed Mater Res A 2010, 94:673-682.
35. Ruvinov E., Leor J., Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011, 32:565-578.
36. Sun Q., Silva E.A., Wang A., Fritton J.C., Mooney D.J., Schaffler M.B., et al. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res 2010, 27:264-271.
37. Sato K., Wu T., Laham R.J., Johnson R.B., Douglas P., Li J., et al. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 2001, 37:616-623.
38. Di Santo S., Yang Z., Wyler von Ballmoos M., Voelzmann J., Diehm N., Baumgartner I., et al. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 2009, 4:e5643.
39. Tang J., Wang J., Zheng F., Kong X., Guo L., Yang J., et al. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 2010, 339(1-2):107-118.
40. Senger D.R., Perruzzi C.A., Streit M., Koteliansky V.E., de Fougerolles A.R., Detmar M. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 2002, 160:195-204.
41. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 2002, 90:223-230.
42. Kutschka I., Chen I.Y., Kofidis T., Arai T., von Degenfeld G., Sheikh A.Y., et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006, 114:I167-I173.
43. Suuronen E.J., Zhang P., Kuraitis D., Cao X., Melhuish A., McKee D., et al. An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 2009, 23:1447-1458.
44. Lanasa S.M., Bryant S.J. Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering. Acta Biomater 2009, 5:2929-2938.